BIOSTAR CAPITAL
BIOSTAR CAPITAL is a Seed, Series A, Series B and Series C+ fund in the US writing $1M–$10M checks into cardiovascular, orthopedic, robotics and medical-tech.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- cardiovascular, orthopedic, robotics, medical-tech
- Check size
- $1M–$10M
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2005
- Assets under management
- $286000000
Thesis
BioStar Capital is a venture capital firm founded in 2005 and headquartered in Charlevoix, Michigan. The firm specializes in identifying and nurturing transformative medical technologies, with a mission to improve patient lives and generate investor returns. Their investment strategy focuses on innovative medical technologies addressing unmet patient needs, particularly in the cardiovascular and orthopedic sectors, with an interest in medical robotics. They favor investments in 'smart' devices, robotics, minimally invasive solutions, cost-reduction technologies, and those improving patient access to care. BioStar Capital invests across seed, Series A, Series B, and growth equity stages, with typical initial investments ranging from $1 million to $10 million. The firm primarily invests in companies located in the United States and often acts as a lead investor, leveraging its deep industry connections and clinical expertise. As of December 2023, the firm announced the closing of Fund V at $130.3 million, bringing their total AUM to over $130 million, with another source indicating $286,000,000.
Common questions
Does BIOSTAR CAPITAL invest at the Seed stage?
Yes. BIOSTAR CAPITAL lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does BIOSTAR CAPITAL write?
BIOSTAR CAPITAL writes $1M–$10M checks.
Where does BIOSTAR CAPITAL invest?
BIOSTAR CAPITAL invests in the US.